Qing Luo

Title: Innovations of Qing Luo

Introduction

Qing Luo is an accomplished inventor based in Nanjing, China. He has made significant contributions to the field of pharmaceuticals and control systems, holding two patents that showcase his innovative spirit and technical expertise.

Latest Patents

One of Qing Luo's latest patents is focused on oral drug dosage forms that comprise a fixed dose of both an ADHD non-stimulant and an ADHD stimulant. This patent describes a formulation that includes an erodible non-stimulant material mixed with an ADHD non-stimulant, as well as an erodible stimulant material mixed with an ADHD stimulant. The design allows for the controlled release of the ADHD non-stimulant and stimulant according to desired profiles, making it a valuable advancement in the treatment of attention deficit hyperactivity disorder (ADHD). Another patent involves a control method that utilizes a context-aware model to define preset controls based on target data meeting specific trigger conditions. This innovation enhances the functionality of context-aware systems, providing a more responsive and efficient user experience.

Career Highlights

Qing Luo has worked with notable companies such as Triastek, Inc. and Huawei Technologies Co., Limited. His experience in these organizations has allowed him to develop and refine his inventions, contributing to advancements in technology and healthcare.

Collaborations

Qing Luo has collaborated with talented individuals, including Feihuang Deng and Xiaoling Li, who have contributed to his projects and innovations.

Conclusion

Qing Luo's work exemplifies the intersection of innovation and practical application in the fields of pharmaceuticals and technology. His patents reflect a commitment to improving treatment options for ADHD and enhancing control systems, marking him as a significant figure in contemporary invention.